throbber

`

`~NA~T~u~R=E~v~o~L~.3~0~2~2t~A~P~R=IL~t9~83~-----------------LETTERSTQNATURE------------------------------------~7~t7
`
`his ser gIn g I y thr phe thr ser asp Glucagon
`his asp glu phe glu arg his ala glu gly thr phe thr ser asp GLP-1
`hIs a I a asp g I y ser phe ser asp g I u GLP-2
`his ser asp gly thr phe thr ser glu Secretin
`his ser asp a I a va I phe thr asp asn VIP
`tyr a I a g I u g I y thr phe
`i I e ser asp G I P
`his a I a asp g I y va I phe thr ser asp PH 1-27
`tyr a I a asp a I a i I e phe thr asn ser
`pGRF
`
`tyr ser lys tyr leu asp ser arg arg ala gin asp phe val gin
`va I ser ser tyr I eu g I u g I y gIn a I a a I a I ys g I u phe i I e a 1 a
`met asn thr i le leu asp ser leu ala thr arg asp phe i le asn
`I eu ser arg I eu arg asp ser a I a arg I eu gIn arg I eu
`I eu gIn
`tyr thr arg leu arg lys gin met ala val
`lys lys tyr leu asn
`tyr ser i I e a I a met asp
`I ys i I e arg gIn gIn asp phe va I asn
`pl:le ser arg I eu
`I eu 9 I y gIn I eu ser a I a I ys
`I ys tyr I eu g I u
`tyr arg lys val
`leu gly gin leu ser ala arg lys leu leu gin
`
`Glucagon
`GLP-1
`GLP-2
`Secretin
`VIP
`GIP
`PHI-27
`pGRF
`
`trp I eu met asn thr
`trp leu val
`lys gly arg gly
`trp leu lie gin thr lys i le thr asp
`9ly leu val
`ser i le leu asn
`trp leu leu ala gin lys gly lys lys ser asp trp lys his asn
`ser leu i le
`asp
`i I e met ser arg gIn gIn g I y g I u ser asn gIn g I u arg 9 I y
`
`lys lys
`
`Glucagon
`GLP-1
`GLP-2
`Secretin
`VIP
`GIP
`PHI-27
`pGRF
`
`I I e thr g I n
`G I P
`ala arg ala arg leu
`pGRF
`Fig. 2 Comparison of the sequences of hamster glucagon-like
`polypeptides with other members of the glucagon-secretin family.
`The peptides are: human glucagon (all mammalian glucagons seem
`to have identical sequences) 32 ; hamster GLP-1 and -2 (this paper);
`porcine secretin, vasoactive intestinal polypeptide (VIP) gastric
`inhibitory polypeptide (GIP) and PHI- 32- 34 ; and human pGRF35 •
`
`ive of the poly(A) tract, it may represent a nearly full-length
`copy of the mRNA. Also, as an approximately 900-base form
`of hamster pancreatic preproglucagon mRNA was not obser(cid:173)
`ved, the proximal AAUAAA, nucleotides 811-816, is not a
`normal signal for polyadenylation.
`The organization of hamster preproglucagon was determined
`by comparing its sequence with that of other glucagon(cid:173)
`containing polypeptides. This analysis suggested that the first
`20, mainly hydrophobic, amino acids constitute the signal pep(cid:173)
`tide. Thus, hamster preproglucagon is 160 amino acids and its
`predicted molecular weight of 18,675 is in good agreement
`with the value of 18,000 determined by Patzelt et a/. 5 for the
`rat precursor. Glucagon is proglucagon(33-61) and is flanked
`by 52 and 99 amino acids at its amino and carboxy terminus,
`respectively. Proglucagon(1-69) possesses 90% homology with
`porcine intestinal glucagon-like immunoreactant 1 (GLI-1) or
`
`glicentin 10 and is probably the corresponding hamster protein
`(Fig. 1). Proglucagon(1-30) is 80% homologous to a porcine
`polypeptide, called glicentin-related pancreatic polypeptide
`(GRPP), which is secreted from the pancreas concomitantly
`with glucagon 11
`• Proglucagon(33-69) is the pancreatic glucagon
`precursor initially described by Tager and Steiner12 and which
`Bataille et at. 13 recently characterized from porcine intestine.
`Because pancreatic proglucagon contains the sequences of both
`pancreatic and intestinal glucagon-containing polypeptides, a
`common precursor may be synthesized in both tissues. The
`carboxy-terminal segment of proglucagon, residues 70-160,
`contains two glucagon-like peptides (GLP) of 37 and 35 amino
`acids, GLP-1 and -2 (Fig. 1). Each polypeptide is flanked by a
`pair of basic amino acids which can be sites of proteolytic
`processing. However, there is no evidence to suggest that the
`Arg-Arg at residues 109, 110 and 124, 125 are cleaved. In
`fact, the Arg-Arg at residues 49, 50 in the glucagon moiety is
`not cleaved. In addition, spacer oligopeptides of 6 and 13
`residues separate glucagon and GLP-1, and GLP-1 and GLP-2,
`respectively. GLP-1 and -2 are related but not identical to
`other members of the glucagon-secretin family of gastro(cid:173)
`intestinal hormones which have been described (Fig. 2).
`Lund et al. 14 have characterized an anglerfish pancreatic
`preproglucagon. This 124-amino acid precursor (M, 14,500) is
`56 amino acids smaller than hamster preproglucagon and this
`difference is due to the absence of the 13-amino acid spacer
`peptide and second glucagon-like peptide (GLP-2) in the
`anglerfish precursor (Fig. 1). Interestingly, this is the first
`example in which the organization of a prohormone has not
`been conserved during vertebrate evolution (compare mam(cid:173)
`16
`malian and fish preproinsulin and preprosomatostatin 15
`'
`).
`Also, in contrast to mammals, anglerfish has another prepro(cid:173)
`glucagon of -12,500M, (refs 17, 18); however, its sequence
`has not been reported. Thus, there may be at least three
`different types of pancreatic proglucagon in vertebrates. Com(cid:173)
`paring hamster and anglerfish preproglucagon, the signal pep(cid:173)
`tide, the amino-terminal peptide (corresponding to GRPP),
`glucagon and GLP-1 possess 25, 10, 69 and 48% amino acid
`homology and 47, 33, 76 and 66% nucleotide homology,
`respectively. The low level of sequence conservation in the
`signal peptide region is not unexpected because the absolute
`sequence of this region is not as important as the maintenance
`of its hydrophobic character19
`• Although the sequence of the
`amino-terminal peptide, that is, proglucagon(1-30), is not con(cid:173)
`served, the size is and this segment may be required for proper
`processing of the precursor. Interestingly, in mammals, the
`
`Fig. 3 Schematic representation
`of the processing of pancreatic pre-
`proglucagon and the structure of
`glucagon-containing polypeptides.
`a, Possible pathway for the pro-
`teolytic processing of pancreatic
`proglucagon. The basic dipeptides
`are indicated and those which are
`potential sites for cleavage are
`dark boxes. The numbers in paren-
`theses at the end of each line are
`the
`sizes
`of
`the glucagon-
`containing
`intermediates deter-
`mined by Patzelt eta/. 5
`• The num-
`bers above the lines are the amino
`acids at the ends of the polypeptide
`in relation to the sequence of pre-
`proglucagon (Fig. 1). b, Structure
`of
`non-pancreatic
`glucagon-
`containing
`polypeptides. GLI
`8,000 and GLI 12,000 are major
`polypeptides in the intestine and
`GLI 9,000 accumulates in
`the
`serum of animals with
`renal
`20
`failure 3
`'
`.
`
`a Pre-{20aa)
`
`NH2 -peptide (30aa)
`
`~ I
`e>
`"" ~
`....
`I
`30 33
`
`Secreted
`
`33
`
`33
`
`GU s.ooo (Giicentinl
`
`I
`
`GLI12,0oo
`
`Gllg.ooo
`
`I
`
`I
`
`(6aal
`
`I I
`e>
`e>
`""
`""
`~ 5
`....
`I I
`
`I I
`
`69 72
`
`I II
`
`GLP·1 (37aa)
`
`GLP-2 (35aa)
`
`(13aa)
`
`I
`"'
`.'(
`~
`I
`
`I
`
`I
`
`I
`~
`e>
`""
`I
`
`I
`
`I
`
`II
`~
`....
`5
`160
`llcM,,1a.ooo>
`160
`II<M,•13.000)
`
`160
`llcM,•4.soo>
`
`(Mr=3,500)
`
`Glucagon (29aa)
`
`II
`.,
`<
`e>
`
`II
`
`II
`
`II
`
`II
`
`' ""
`'
`'
`' 61
`' Secreted
`
`II
`
`II
`
`II
`
`69
`
`I
`
`I I
`61
`I
`
`108
`I
`
`© Nature Publishing Group
`1983
`
`MPI EXHIBIT 1049 PAGE 2
`
`

`

`NATURE VOL. 302 21 APRIL 1983
`
`718
`
`lE II ERSTO NATURE
`sequence of proglucagon(1-30) is conserved to a greater extent
`than the C-peptide of proinsulin. For example, there is 80%
`homology between hamster and porcine proglucagon(1-30) and
`only 48% homology between their insulin C-peptides. The
`corresponding values in a comparison of hamster and human
`are 83% and 65%, respectively (G.I.B., unpublished). The
`spacer peptide which separates glucagon and GLP-1 is 6 amino
`acids in hamster and 5 in anglerfish and the sequence is different.
`The GLP-1 region possesses extensive homology between ham(cid:173)
`ster and anglerfish, especially the segment corresponding to
`hamster proglucagon(78-100). However, hamster GLP-1 has
`a 6-amino acid amino-terminal extension which is absent in
`anglerfish. The sequence conservation in the GLP-1 region
`suggests that this peptide has a biological function. We have
`also compared hamster GLP-2 with the anglerfish GLP and
`they possess only 29% amino acid sequence homology. The 5'(cid:173)
`and 3'-untranslated portions of hamster and anglerfish mRNA
`possess no significant regions of homology.
`The pancreas and intestine are the major sites of synthesis
`of glucagon and glucagon-containing polypeptides. Figure 3 is
`a possible scheme for the processing of proglucagon in the
`pancreas. This model is based on the structure of prepro(cid:173)
`glucagon presented here, the sizes and order of appearance of
`intermediates in the processing of rat proglucagon and the
`assumption that processing occurs at basic dipeptides. As indi(cid:173)
`cated, both glucagon and proglucagon(1-30) are secreted 11
`•
`However, the fate of proglucagon(72-160) and the two
`glucagon-like polypeptides is unknown. Intestinal glucagon(cid:173)
`containing polypeptides are present at less than 1% the levels
`of pancreatic glucagon and the major polypeptides have M,s
`of 8,000 and 12,000 (ref. 20). The 8,000-M, protein is GLI-1
`and corresponds
`to proglucagon(1-69)
`(Figs 1, 3). The
`sequence of the 12,000-M, polypeptide has not been deter(cid:173)
`20
`mined but its size, biochemical and immunological properties3
`'
`are consistent with it being proglucagon(1-108), and thus it
`would include both glucagon and GLP-1 (Figs 1, 3). In addition,
`a 9,000-M, peptide with glucagon-like immunoreactivity has
`been described which accumulates in the plasma of animals
`with renal failure 1
`20
`3
`• Its size, biochemical and immunological
`-
`'
`properties suggest that it may correspond to proglucagon(1-61)
`(Fig. 3).
`Glucagon and insulin have a major role in the regulation of
`plasma glucose levels. The biological role(s) of the intestinal
`glucagon-containing polypeptides is unclear although GLI-1
`seems to inhibit gastric acid secretion21
`• Both the pancreatic
`and intestinal glucagon-containing polypeptides are probably
`derived from a common precursor which is processed differently
`in these two tissues. The processing of proglucagon can poten(cid:173)
`tially generate at least 11 unique polypeptides, 8 of which have
`been identified biochemically or immunochemically. As the
`sequence of proglucagon is now known, it will be possible to
`synthesize polypeptides and to produce antisera to specific
`segments or polypeptides contained within the precursor22
`• The
`processing of the precursor in different tissues and the function
`of this family of glucagon-containing polypeptides in normal
`and disease states can then be critically examined. The
`difference in structure between mammalian and anglerfish pro(cid:173)
`glucagon is unusual. The presence of an additional glucagon(cid:173)
`like peptide in the mammalian precursor suggests that duplica(cid:173)
`tion or loss of a segment of the proglucagon gene has occurred.
`Examination of the structure of the gene may elucidate the
`evolutionary history of this hormone.
`We thank our colleagues at Lilly Research Laboratories who
`helped in the isolation of the islets, Ms M. Quiroga and N.
`Pong for their technical assistance, Dr W. J. Rutter for his
`encouragement and suppport, Drs Leslie B. Rail and Pablo
`Valenzuela for their assistance in writing and Dr R. Najarian
`and Ms Maureen Appling who prepared the figures and typed
`the manuscript.
`Received 2 December 1982; accepted 16 February 1983.
`
`2. Unger, R. H. & Orci, L. (eds) Glucagon . Physiology. Pathophysiology and Morpholog y of
`the Pancreatic A-Cell (Elsevier, New York, 1981).
`3. Conlon, J. M. Diabetologia 18, 85-88 (1980).
`4. Unger, R. H. & Orci, L. New Engl. J. Med. 304, 1518-1524 (1981).
`5. Patzelt, C., Tager, H. S., Carroll, R. S. & Steiner, D. F. Nature Z82, 260-266 (1979).
`6. Proudfoot, N.J. & Brownlee, G . G. Nature 263,211-214 (1976).
`7. Fitzgerald, M. & Shenk, T. Celt 14,251-260 (1981 ).
`8. Carmichael, G. C. & McMaster, G. K. Meth. Enzym. 65, 380-391 (1980).
`9. Thomas, P. S. Proc. natn. Acad. Sci. U.S.A. 77, 5201-5205 (1980).
`10. Thim, L. & Moody, A. J. Regulatory Peprides 1, 139- 150 (1981).
`11. Moody, A. J., Holst, J. J., Tbim, L. & Lindkaer, Jenson, S. Nature 289,514-516 (1981 ).
`12. Tager, H. S. & Steiner, D. F. Proc. natn. Acad. Sci. U.S.A. 70, 2321-2325 (1973).
`13. Bataille, D. er al. FEBS Lert. 146, 79-86 (1982).
`14. Lund, P. K., Goodman, R. H .• Dee. P. C. & Habener, J. F. Proc. natn. Acad. Sci. U.S.A .
`79, 345-349 (1982).
`IS. Shen, L. P., Pictet, R. L. & Rutter, W. J . Proc. narn. Acad. Sci. U.S.A. 79, 4575-4579
`(1982).
`16. Chan, S. J. era/. J. bioi. Chem . 256,7595-7602 (1981).
`17. Lund, P. K., Goodman, R. H. & Habener, J. F. J. bioi. Chem. 256,6515-6518 (1981).
`18. Shields, D., Warren, T. G .• Roth, S. E. & Brenner, M. J. Nature 289, 511-514 (1981).
`19. Steiner, D. F., Quinn, P. S. , Chan, S. J., Marsh, J. & Tager, H. S. Ann. N . Y. A cad. Sci.
`343, 1- 16 (1980).
`20. Tager, H. S. & Markese, J. J. bioi. Chem. 254, 2229- 2233 (1979).
`21. Kirkegaard, P. et al. Nature 297, 156-157 (1982).
`22. Lerner, R. A. Nature 299, 592-596 (1982).
`23. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J. Biochemistry 18,
`5294-5299 (1979).
`24. Santerre, R F. er al. Proc. narn. Acad. Sci. U.S.A. 78, 4339-4343 (1981).
`25. Land, H., Grez, M., Hauser, H., Lindenmaier, W. & Schutz, G. Nucleic Acids Res. 9,
`2251-2266 (1981).
`26. Villa-Komarof!, L. er al. Proc. natn. Acad. Sci. U.S.A. 75, 3727-3731 (1978).
`27. Gergen, J.P., Stern, R. H. & Wensink, P. C. Nucleic Acids Res. 7, 2115-2136 (1979).
`28. Comb, M., Seeburg, P. H., Adelman, J., Eiden, L. & Herbert, E . Nature 19!, 663-666
`(1982).
`29. Beaucage, S. L. & Caruthers, M. H . Tetrahedron Lett. 21, 1859-1862 (1981 ).
`30. Bell, G . I. er al. Nature Z82, 525-527 (1979).
`31. Maxam, A . M. & Gilbert, W. Merh. Enzym. 65, 499- 560 (1980).
`32 . Dayhoff, M. 0 . Arias of Protein Sequence and Structure Vol. S, Suppl. 2, 125- 126 (National
`Biomedical Research Foundation, WashinStton. DC. 1976 ).
`33. Tatemoto, K. & Mutt, V. Proc. natn. A cad. Sci. U.S.A. 78,6603-6607 (1981).
`34 . Jornval. H. et al. FEBS Lett. 123,205-216 (1981 ).
`35. Guillemin, R. et al. Science 218,585-587 (1982).
`
`A new troponin T and eDNA clones
`for 13 different muscle
`proteins, found by shotgun sequencing
`Scott D. Putney*, Walter C. Herlihyt
`& Paul Schimmel*
`*Department of Biology and t Department of Chemistry,
`Massachusetts Institute of Technology, Cambridge,
`Massachusetts 02139, USA
`
`Complete amino acid sequences have been estabHshed for 19
`muscle-related proteins and these proteins are each sufficiently
`abundant to suggest that their mRNA levels are about 0.4%
`or higher. Based on these considerations, a simple theoretical
`analysis shows that clones for most of these proteins can be
`identified within a complementary DNA library by sequencing
`eDNA inserts from 150-200 randomly selected clones. This
`procedure should not only rigorously identify specific clones,
`but it could also uncover amino acid sequence variants of major
`muscle proteins such as the troponins1-.s. We have determined
`sequences for about 20,000 nucleotides within 178 randomly
`selected clones of a rabbit muscle eDNA library, and report
`here that in addition to finding sequences encoding the two
`known skeletal muscle isotypes of troponin C7
`-9, we have dis(cid:173)
`covered sequences encoding two forms of troponin T. Over the
`region of nucleotide sequence overlap in the troponin T clones,
`the new isotype diverges significantly from its counterpart10
`•
`Altogether, clones for 13 of the 19 known muscle-specific
`proteins were identified, in addition to the clone for the new
`troponin T isotype.
`To identify a clone for a particular protein by DNA sequen(cid:173)
`cing, the nucleotide sequence of a eDNA clone encoding a
`portion of the protein sequence must be determined. We deter(cid:173)
`mined sequences of eDNA fragments isolated from a library
`of rabbit muscle eDNA cloned into M13 phage 11
`• Before clon(cid:173)
`ing, the eDNA was restricted with Mspi, Taql or Sau3AI so
`that eDNA fragments of -250 base pairs (bp) were actually
`cloned. Sequences of -110 nucleotides from 178 different
`phage inserts were determined. The sequences were translated
`
`1. Foa, P., Bajaj, J. & Foa, N. (eds) Glucagon: Irs Role in Physiology and Clinical Medicine
`(Springer, Berlin, 1977).
`
`0028-0836/ 83/ 160718--04$01.00
`
`© 1983 Macmillan Journals Ltd
`
`MPI EXHIBIT 1049 PAGE 3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket